INSERM (Institut National de la Santé et de la Recherche Médicale) UMR1186, Laboratory Integrative Tumor Immunology and Genetic Oncology, France. INSERM, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France.
INSERM (Institut National de la Santé et de la Recherche Médicale) UMR1186, Laboratory Integrative Tumor Immunology and Genetic Oncology, France. Centre Chirurgical Marie-Lannelongue, Service d'Anatomie Pathologique, LePlessis-Robinson, France.
Cancer Res. 2016 Apr 1;76(7):1757-69. doi: 10.1158/0008-5472.CAN-15-1545. Epub 2016 Feb 26.
Homing of CD8(+) T lymphocytes to the tumor microenvironment is an important step for mounting a robust antitumor immune response. TGFβ is responsible for CD103 (αEβ7) integrin induction in activated intraepithelial CD8(+) T lymphocytes. However, the interplay between TGFβ and CD103 and their contribution to T-cell infiltration and antitumor activity remain unknown. Here, we used viable human lung tumor slices and autologous tumor antigen-specific T-lymphocyte clones to provide evidence that CD103 is directly involved in T-lymphocyte recruitment within epithelial tumor islets and intratumoral early T-cell signaling. Moreover, TGFβ enhanced CD103-dependent T-cell adhesion and signaling, whereas it inhibited leukocyte function-associated antigen (LFA)-1 (αLβ2) integrin expression and LFA-1-mediated T-lymphocyte functions. Mechanistic investigations revealed that TGFβ bound to its receptors (TGFBR), which promoted the recruitment and phosphorylation of integrin-linked kinase (ILK) by TGFBR1. We further show that ILK interacted with the CD103 intracellular domain, resulting in protein kinase B (PKB)/AKT activation, thereby initiating integrin inside-out signaling. Collectively, our findings suggest that the abundance of TGFβ in the tumor microenvironment may in fact engage with integrin signaling pathways to promote T-lymphocyte antitumor functions, with potential implications for T-cell-based immunotherapies for cancer. Cancer Res; 76(7); 1757-69. ©2016 AACR.
CD8(+) T 淋巴细胞归巢到肿瘤微环境是引发强大抗肿瘤免疫反应的重要步骤。TGFβ 负责激活的上皮内 CD8(+) T 淋巴细胞中 CD103(αEβ7)整合素的诱导。然而,TGFβ 与 CD103 的相互作用及其对 T 细胞浸润和抗肿瘤活性的贡献仍不清楚。在这里,我们使用可行的人肺肿瘤切片和自体肿瘤抗原特异性 T 淋巴细胞克隆,提供了证据表明 CD103 直接参与上皮肿瘤胰岛内和肿瘤内早期 T 细胞信号转导的 T 淋巴细胞募集。此外,TGFβ 增强了 CD103 依赖性 T 细胞黏附和信号转导,而抑制了白细胞功能相关抗原(LFA)-1(αLβ2)整合素表达和 LFA-1 介导的 T 细胞功能。机制研究表明,TGFβ 与 TGFBR 结合,促进 TGFBR1 募集和整合素连接激酶(ILK)的磷酸化。我们进一步表明,ILK 与 CD103 细胞内结构域相互作用,导致蛋白激酶 B(PKB)/AKT 激活,从而启动整合素的内信号转导。总之,我们的研究结果表明,肿瘤微环境中 TGFβ 的丰度实际上可能与整合素信号通路相互作用,以促进 T 淋巴细胞的抗肿瘤功能,这可能对基于 T 细胞的癌症免疫疗法具有重要意义。Cancer Res; 76(7); 1757-69. ©2016 AACR.